ABCDEFGHIJKLMNOPQRSTUVWXYZ
1
BiotechIPO DateHeadquartersTickerShs SoldIPO $/ShIPO ProceedsInsider %Insider DollarsInsider OptionalIPO SEC LinkDate FoundedPre-IPO SharesIPO Pre- MoneyShs Post-IPOPost IPO Mkt CapMost AdvancedPlatformTherapeutic Area
2
Kymera21-Aug-20MassKYMR8.68$20.00$173.60Link201734.46$689.243.1$862.80Preclinical
Protein degradation
Inflammation & cancer
3
Harmony Biosciences17-Aug-20PennsylvaniaHRMY5.35$24.00$128.40Link201758.33$1,399.963.7$1,528.32MktNoneCNS, Narcolepsy
4
Inhibrx17-Aug-20SoCalINBX7.00$17.00$119.00Link201729.66$504.236.7$623.22Phase IMonoclonalsCancer MOA
5
CureVac13-Aug-20GermanyCVAC13.33$16.00$213.28Link2015162.64$2,602.2176.0$2,815.52Phase IRNA vaccinesInfections
6
Checkmate Pharm06-Aug-20MassCMPI5.00$15.00$75.00Link201516.44$246.621.4$321.60Phase IIVLP technologyCancer MOA
7
Freeline06-Aug-20EnglandFRLN8.82$18.00$158.765%$7.94YesLink201517.10$307.825.9$466.56Phase I/IIGene TherapyBlood disorders
8
AlloVir29-Jul-20MassALVR16.25$17.00$276.25Link201346.42$789.162.7$1,065.39Phase IIcell therapyAntivirals
9
Annexon23-Jul-20NorCalANNX14.75$17.00$250.75Link201121.25$361.336.0$612.00Phase IComplement inhibAutoimmune & CNS
10
Inozyme Pharma23-Jul-20MassINZY7.00$16.00$112.00Link201515.31$245.022.3$356.96PreclinicalNoneGenetic diseases
11
iTeos Therapeutics23-Jul-20Mass/BelgiumITOS10.59$19.00$201.21Link201122.84$434.033.4$635.17Phase IDrug designCancer MOA
12
Nurix Therapeutics23-Jul-20NorCalNRIX11.00$19.00$209.00Link200926.04$494.837.0$703.76PreclinicalDrug designCancer MOA
13
ALX Oncology16-Jul-20NorCal/IrelandALXO8.50$19.00$161.50Link201526.71$507.535.2$668.99Phase IDrug designCancer MOA
14
Berkeley Lights16-Jul-20NorCalBLI8.10$22.00$178.20Link201153.54$1,177.961.6$1,356.08MktCell biologyReagents
15
Pandion Therapeutics16-Jul-20MassPAND7.50$18.00$135.00Link201621.03$378.528.5$513.54Phase IDrug designAutoimmune
16
Renalytix AI plc16-Jul-20New York/UKRLNX11.00$6.75$74.25Link201859.42$401.170.4$475.34MktDiagnosticKidney disease
17
Relay Therapeutics15-Jul-20MassRLAY20.00$20.00$400.00Link201566.88$1,337.686.9$1,737.60Phase IDrug designCancer MOA
18
Inventiva09-Jul-20FranceIVA7.48$14.40$107.71Link201130.69$441.938.2$549.65Phase IINoneLiver disease, Genetic
19
Nkarta09-Jul-20NorCalNKTX14.00$18.00$252.00Link201516.43$295.730.4$547.74Preclinicalcell therapyCancer MOA
20
Poseida Therapeutics09-Jul-20SoCalPSTX14.00$16.00$224.00Link201447.82$765.161.8$989.12Phase IICell & gene therapyCancer
21
Akouos25-Jun-20MassAKUS12.50$17.00$212.50Link201619.98$339.732.5$552.16PreclinicalGene TherapyEar, Nose, Throat
22
Fusion Pharmaceuticals25-Jun-20OntarioFUSN12.50$17.00$212.50Link201429.16$495.741.7$708.22Phase IradiotherapyCancer
23
PolyPid25-Jun-20IsraelPYPD3.75$16.00$60.0045%$27.00YesLink200813.30$212.817.1$272.80Phase IIIFormulationMultiple
24
Progenity19-Jun-20SoCalPROG6.67$15.00$100.0550%$50.03Link201238.49$577.445.2$677.40MktNoneDiagnostics
25
Forma Therapeutics18-Jun-20MassFMTX13.88$20.00$277.60Link201125.12$502.439.0$780.00Phase IINoneCancer & genetic
26
Genetron Holdings18-Jun-20ChinaGTH80.00$3.20$256.008%$20.48Link2015361.81$1,157.8441.8$1,413.79MktDiagnosticCancer
27
Repare Therapeutics18-Jun-20QuebecRPTX11.00$20.00$220.00Link201624.02$480.435.0$700.40PreclinicalGene profilesCancer MOA
28
Royalty Pharma15-Jun-20New YorkRPRX60.00$28.00$1,680.00Link1996535.39$14,990.9595.4$16,670.92MktNoneMultiple
29
Avidity Biosciences11-Jun-20SoCalRNA14.40$18.00$259.20Link201220.95$377.135.4$636.30PreclinicalOligo-AntibodiesGenetic diseases
30
Burning Rock Biotech11-Jun-20ChinaBNR13.50$16.50$222.7535%$77.96Link201488.28$1,456.6101.8$1,679.37MktNoneDiagnostics, Cancer
31
Generation Bio11-Jun-20MassGBIO10.53$19.00$199.99Link201634.10$647.944.6$847.89PreclinicalGene TherapyLiver disease, Eye
32
Vaxcyte11-Jun-20NorCalPCVX15.63$16.00$250.00Link201332.76$524.248.4$774.16PreclinicalVaccine designInfections
33
Lantern Pharma10-Jun-20DallasLTRN1.75$15.00$26.25Link20134.47$67.16.2$93.30Phase IIBioinformaticsCancer
34
Legend Biotech08-Jun-20New JerseyLEGN36.85$11.50$423.78Link2014221.64$2,548.9258.5$2,972.64Phase IIcell therapyCancer MOA
35
Applid Molecular Transport
04-Jun-20NorCalAMTI11.00$14.00$154.00Link201021.40$299.632.4$453.60Phase IActive cell transportGastrointestinal
36
Calliditas Therapeutics04-Jun-20SwedenCALT9.23$9.75$89.99Link200438.71$377.447.9$467.42Phase IIINoneOrphan diseases
37
Pliant Therapeutics03-Jun-20NorCalPLRX9.63$16.00$154.00Link201524.58$393.334.2$547.28Phase IINoneLiver disease
38
ADC Therapeutics14-May-20SwitzerlandADCT12.25$19.00$232.75No AmtLink201156.64$1,076.268.9$1,308.91Phase IIAb conjugatesCancer MOA
39
Ayala Pharmaceuticals07-May-20IsraelAYLA3.67$15.00$55.01Link20178.78$131.712.4$186.71Phase IINotch pathwayCancer MOA
40
Lyra Therapeutics30-Apr-20MassLYRA3.50$16.00$56.00Link20058.90$142.412.4$198.40Phase IIENT deliveryEar, Nose, Throat
41
Oric Pharmaceuticals23-Apr-20NorCalORIC7.50$16.00$120.00Link201421.29$340.628.8$460.64Phase IDrug designCancer MOA
42
Keros Therapeutics07-Apr-20MassKROS6.00$16.00$96.00Link201513.19$211.019.2$307.04Phase ITGFbeta signalingBlood disorders
43
Zentalis Pharmaceuticals02-Apr-20New YorkZNTL9.18$18.00$165.24Link201425.32$455.834.5$621.00Phase IDrug designCancer MOA
44
IMARA11-Mar-20MassIMRA4.70$16.00$75.20Link201611.88$190.116.6$265.28Phase IINoneGenetic diseases
45
Passage BIO27-Feb-20PhiladelphiaPASG12.00$18.00$216.00Link201732.00$576.044.0$792.00PreclinicalGene TherapyCNS
46
Revolution Medicines12-Feb-20NorCalRVMD14.00$17.00$238.00Link201442.90$729.356.9$967.30Phase IDrug designCancer MOA
47
Beam Therapeutics05-Feb-20MassBEAM10.59$17.00$180.03Link201739.07$664.249.7$844.22LeadGene editingMultiple
48
PPD05-Feb-20N CarolinaPPD60.00$27.00$1,620.002%$32.40YesLink2017279.43$7,544.6339.4$9,164.61MktNoneCRO
49
Schrodinger05-Feb-20New YorkSDGR11.88$17.00$201.96Link199049.57$842.761.5$1,044.65MktBioinformaticsSoftware
50
Arcutis Biotherapeutics30-Jan-20SoCalARQT9.38$17.00$159.4631%$49.43YesLink201627.25$463.336.6$622.71Phase IIINoneDermatology
51
Annovis Bio29-Jan-20PennsylvaniaANVS2.00$6.00$12.007%$0.80YesLink20084.52$27.16.5$39.12Phase IIDrug designCNS
52
Black Diamond Therapeutics
29-Jan-20MassBDTX10.59$19.00$201.21Link201423.73$450.934.3$652.08PreclinicalDrug designCancer MOA
53
AnPac Bio-Medical Sci28-Jan-20ChinaANPC1.33$12.00$15.9611%$1.74Link20109.87$118.411.2$134.40MktNoneDiagnostics, Cancer
54
I-Mab Biopharma16-Jan-20ChinaIMAB17.04$6.09$103.7228%$28.73Link2014114.20$695.1131.2$798.86Phase IIINoneCancer & Autoimmune
55
Galera Therapeutics12-Nov-19PennsylvaniaGRTX5.00$12.00$60.0067%$39.96YesLink201219.36$232.324.4$292.32Phase IIIradiotherapyCancer
56
89Bio11-Nov-19Israel/NorCalETNB5.30$16.00$84.8060%$50.88Link20187.69$123.013.0$207.84Phase INoneLiver disease
57
CNS Pharmaceuticals07-Nov-19TexasCNSP2.13$4.00$8.50Link201713.59$54.415.7$62.86PreclinicalNoneCancer
58
TELA Bio07-Nov-19PennsylvaniaTELA4.00$13.00$52.00Link20127.01$91.111.0$143.13MktNoneDermatology, Tissue reconstruction
59
Centogene B.V.06-Nov-19GermanyCNTG4.00$14.00$56.0054%$30.02Link201815.86$222.019.9$278.04MktBioinformaticsGenetic diseases
60
Oyster Point Pharma30-Oct-19New JerseyOYST5.00$16.00$80.00Link201515.61$249.820.6$329.76Phase IIINoneEye diseases
61
RAPT Therapeutics30-Oct-19NorCalRAPT3.00$12.00$36.0044%$15.70Link201518.28$219.421.3$255.36Phase IDrug designCancer MOA
62
Happiness Biotech Group25-Oct-19ChinaHAPP2.00$5.50$11.00Link200423.00$126.525.0$137.50MktNoneNutriceuticals
63
Cabaletta Bio24-Oct-19PhiladelphiaCABA6.80$11.00$74.805%$3.74YesLink201716.75$184.323.6$259.05Phase Icell therapyAutoimmune
64
Phathom Pharm24-Oct-19IllinoisPHAT9.56$19.00$181.64Link201817.99$341.827.6$523.45Phase IINoneGastrointestinal
65
Innate Pharma16-Oct-19FranceIPHA12.50$5.50$68.75Link199964.04$352.276.5$420.97MktMonoclonalsCancer
66
Vir Biotechnology10-Oct-19NorCalVIR7.14$20.00$142.80Link2016102.26$2,045.2109.4$2,188.00Phase IIMonoclonals & RNAiInfections
67
BioNTech09-Oct-19GermanyBNTX10.00$15.00$150.00Link2008216.26$3,243.9226.3$3,393.90Phase IIImmunotherapyCancer
68
Aprea Therapeutics02-Oct-19Sweden/MassAPRE5.67$15.00$85.05Link200214.21$213.219.9$298.20Phase IIINoneCancer MOA
69
Frequency Therapeutics02-Oct-19MassFREQ6.00$14.00$84.00Link201424.45$342.330.5$426.30Phase Icell therapyMultiple
70
Viela Bio02-Oct-19MarylandVIE7.90$19.00$150.1047%$69.95Link201741.77$793.649.7$943.73FiledMonoclonalsAutoimmune
71
Exagen Diagnostics18-Sep-19SoCalXGN3.60$14.00$50.4024%$12.00YesLink20027.89$110.511.5$160.86MktDiagnosticAutoimmune
72
IGM Biosciences17-Sep-19NorCalIGMS10.94$16.00$175.04Link199317.95$287.228.9$462.24PreclinicalMonoclonalsCancer
73
Satsuma Pharmaceuticals12-Sep-19NorCalSTSA5.50$15.00$82.5030%$25.00Link201611.11$166.716.6$249.15Phase IIINoneCNS, Migraines
74
SpringWorks Therapeutics
12-Sep-19ConnecticutSWTX9.00$18.00$162.00Link201732.88$591.841.9$753.84Phase IIINoneCancer
75
10x Genomics11-Sep-19NorCalTXG10.00$39.00$390.00Link201283.85$3,270.293.9$3,660.15MktBioinformaticsInstrumentation
76
Castle Biosciences24-Jul-19TexasCSTL4.00$16.00$64.0023%$14.98YesLink200712.05$192.816.1$256.80MktGene profilesDiagnostics, Cancer
77
Genmab22-Jul-19DenmarkGMAB2.85$177.50$505.88Link199861.52$10,919.864.4$11,425.68Phase IIMonoclonalsCancer
78
Fulcrum Therapeutics17-Jul-19MassFULC4.50$16.00$72.00Link201518.84$301.423.3$373.44Phase ICell screeningGenetic diseases
79
Mirum Pharmaceuticals17-Jul-19NorCalMIRM5.00$15.00$75.0047%$35.03YesLink201818.02$270.323.0$345.30Phase IIINoneLiver disease
80
Karuna Therapeutics27-Jun-19MassKRTX5.58$16.00$89.2834%$30.00YesLink200917.00$272.022.6$361.28Phase IINoneCNS Psychiatric
81
Adaptive Biotechnologies26-Jun-19SeattleADPT15.00$20.00$300.00Link2009105.97$2,119.4121.0$2,419.40MktBioinformaticsDiagnostics
82
BridgeBio Pharma26-Jun-19NorCalBBIO20.50$17.00$348.50Link2015100.00$1,700.0120.5$2,048.50Phase IIIGenetic diseasesMultiple
83
Morphic Holding26-Jun-19MassMORF6.00$15.00$90.0033%$29.97YesLink201423.60$354.029.6$444.00PreclinicalIntegrin biologyAutoimmune
84
Akero Therapeutics19-Jun-19NorCalAKRO5.75$16.00$92.0033%$29.99YesLink201721.30$340.827.1$432.80Phase IINoneLiver disease
85
Atreca19-Jun-19NorCalBCEL7.35$17.00$124.9550%$62.97Link201019.43$330.326.8$455.26PreclinicalMonoclonalsCancer
86
Personalis19-Jun-19NorCalPSNL7.92$17.00$134.64Link201121.83$371.129.8$505.75MktBioinformaticsDiagnostics, Cancer
87
Prevail Therapeutics19-Jun-19New YorkPRVL7.35$17.00$124.95Link201726.65$453.134.0$578.00PreclinicalGene TherapyCNS
88
Stoke Therapeutics18-Jun-19MassSTOK7.89$18.00$142.02Link201423.57$424.331.5$566.28PreclinicalAntisenseGenetic diseases
89
Bicycle Therapeutics22-May-19EnglandBCYC4.33$14.00$60.6241%$24.98YesLink200913.37$187.217.7$247.80Phase IPeptidesCancer MOA
90
IDEAYA Biosciences22-May-19NorCalIDYA5.00$10.00$50.0060%$30.00Link201514.48$144.819.5$194.80Phase IDrug designCancer MOA
91
Axcella Health08-May-19MassAXLA3.57$20.00$71.4055%$38.98YesLink200819.42$388.423.0$459.80PreclinicalNoneLiver disease
92
Cortexyme08-May-19NorCalCRTX4.41$17.00$74.9735%$26.31Link201221.60$367.226.0$442.17Phase INoneCNS, Alzheimer's
93
Milestone Pharmaceuticals
08-May-19QuebecMIST5.50$15.00$82.50Link200318.15$272.323.7$354.75Phase IIINoneCardio
94
NextCure08-May-19MarylandNXTC5.00$15.00$75.0043%$32.03Link201516.94$254.121.9$329.10Phase IImmunotherapyCancer
95
Trevi Therapeutics07-May-19ConnecticutTRVI5.50$10.00$55.0055%$29.98YesLink201110.77$107.716.3$162.70Phase IIINoneCNS & Respiratory
96
HOOKIPA Pharma17-Apr-19Austria/NYHook6.00$14.00$84.0066%$55.02YesLink201119.41$271.725.4$355.74Phase IIGene TherapyAntivirals & I/O
97
Turning Point Therapeutics
16-Apr-19SoCalTPTX9.25$18.00$166.5029%$48.29Link201320.40$367.229.7$533.70Phase IDrug designCancer MOA
98
Precision BioSciences27-Mar-19Durham, NCDTIL7.90$16.00$126.40Link200641.13$658.149.0$784.48PreclinicalGenome editingCancer & genetic
99
Genfit26-Mar-19Loos, FranceGNFT6.65$20.32$135.13Link199931.18$633.637.8$768.71Phase IIINoneEndocrine, Liver
100
Kaleido Biosciences27-Feb-19MassKLDO5.00$15.00$75.00Link201524.63$369.529.6$444.45PreclinicalMicrobiomeEndocrine